Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Plymouth Meeting, PA
SEC filing record 1 source field available
Fiscal year end
31 December
INOVIO PHARMACEUTICALS, INC. has filed 1,289 SEC EDGAR filings since 29 Jun 1999

SEC filing history

Showing 726-750 of 873 matching filings.

Per page
25
Current page
30
PRE 14A File 001-14888

PRELIMINARY PROXY STATEMENT

Filing date
18 Mar 2013
Reporting date
17 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-60487

SC 13G

Filing date
15 Mar 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-176670

424B5

Filing date
07 Mar 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14888

FORM 8-K

Filing date
07 Mar 2013
Reporting date
06 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-176670

FORM 424B5

Filing date
07 Mar 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
16 Jan 2013
Reporting date
15 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-60487

INOVIO PHARMACEUTICALS 13G/A

Filing date
10 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
08 Jan 2013
Reporting date
04 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Dec 2012
Reporting date
03 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Nov 2012
Reporting date
28 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Nov 2012
Reporting date
26 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Nov 2012
Reporting date
21 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2012
Reporting date
19 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Nov 2012
Reporting date
15 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Nov 2012
Reporting date
13 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Nov 2012
Reporting date
08 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Nov 2012
Reporting date
01 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Oct 2012
Reporting date
26 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Oct 2012
Reporting date
24 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Oct 2012
Reporting date
22 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Oct 2012
Reporting date
12 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Oct 2012
Reporting date
10 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
16 Aug 2012
Reporting date
15 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .